<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Rocket Pharmaceuticals, Inc. (RCKTW)</title>
    <description>Latest news, press releases, and SEC filings for Rocket Pharmaceuticals, Inc. (RCKTW)</description>
    <link>https://caymanjournal.com/stock/RCKTW</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 21:33:03 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/RCKTW/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>DEF 14A — ROCKET PHARMACEUTICALS, INC.</title>
      <description># 🧾 What This Document Is  
This is Rocket Pharmaceuticals&apos; **definitive proxy statement (DEF 14A)**. It&apos;s an official invitation and information packet for shareholders ahead of the **2026 Annual Meeting on May 20, 2026**. The purpose is to let shareholders vote on key company decisions.  
👉 *Why</description>
      <link>https://caymanjournal.com/stock/RCKTW/sec-filing/0001140361-26-013335</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/RCKTW/sec-filing/0001140361-26-013335</guid>
      <pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>